A New Class of Dual‐Targeted Antivirals: Monophosphorylated Acyclovir Prodrug Derivatives Suppress Both Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2
2010 ◽
Vol 201
(4)
◽
pp. 635-643
◽
2003 ◽
Vol 187
(10)
◽
pp. 1513-1521
◽
2005 ◽
Vol 43
(8)
◽
pp. 4215-4217
◽
2008 ◽
Vol 198
(2)
◽
pp. 241-9
◽
2000 ◽
Vol 182
(4)
◽
pp. 1090-1096
◽
2013 ◽
Vol 346
(2)
◽
pp. 108-112
◽
1998 ◽
Vol 178
(6)
◽
pp. 1616-1622
◽
2007 ◽
Vol 109
(2, Part 1)
◽
pp. 403-409
◽
1996 ◽
Vol 70
(10)
◽
pp. 6937-6946
◽